Canada Markets closed

Emerald Health Therapeutics, Inc. (EMHTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1405-0.0049 (-3.37%)
At close: 3:54PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 528.43M
Enterprise Value 328.12M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.15
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 3-89.74%
S&P500 52-Week Change 3N/A
52 Week High 31.7700
52 Week Low 30.0700
50-Day Moving Average 30.1417
200-Day Moving Average 30.1529

Share Statistics

Avg Vol (3 month) 3394.23k
Avg Vol (10 day) 3332.53k
Shares Outstanding 5200.14M
Float 159.98M
% Held by Insiders 121.06%
% Held by Institutions 14.54%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-15.05%
Return on Equity (ttm)-80.96%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)35.60%
Gross Profit (ttm)-10.79M
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.1290
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)27.51
Current Ratio (mrq)0.59
Book Value Per Share (mrq)0.94

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A